Vimarsana
Biggest News Aggregation in the World

Page 3 - Deep Digital Cornwall News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deep Digital Cornwall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deep Digital Cornwall Today - Breaking & Trending Today

Today's Market View - Adriatic Metals; Arc Minerals; Caledonia Mining; Strategic Minerals; Power Metal Resources; Sunrise Resources and more... - Vimarsana News

Today's Market View - Adriatic Metals; Arc Minerals; Caledonia Mining; Strategic Minerals; Power Metal Resources; Sunrise Resources and more...

Adriatic Metals* (LON:ADT1) (ASX:ADT) – Acquisition of RAS Metals Arc Minerals* (AIM:ARCM) – Change of accounting reference date and issue of 1.2m new...

Deep Digital Cornwall project aims to unlock resources - Vimarsana News

Deep Digital Cornwall project aims to unlock resources

Deep Digital Cornwall project aims to unlock resources Aerial view Cornwall mines. Image by suziedoe from Pixabay . The underground environment is the subject of a major new £4 million project launched to create a world-leading cluster of research-intensive digital businesses in Cornwall and the Isles of Scilly. The pioneering project, called Deep Digital Cornwall, led by the Camborne School of Mines (CSM) with the Institute for Data Science and Artificial Intelligence at the University of Exeter, will conduct research and champion innovation with 40 of the region’s SMEs. Sign Up for the ...

Source: mining.com
Scancell Holdings PLC comments on sharp share price increase - Vimarsana News

Scancell Holdings PLC comments on sharp share price increase

Follow John on: A look at some of the major movers in London on Monday Scancell Holdings PLC (LON:SCLP) soared 55% to 21.25p, prompting the company to put out a statement about the share price movement. The developer of novel immunotherapies for the treatment of cancer and infectious disease noted the recent press coverage and the share price increase and referred shareholders to its interim results statement of January 29, where it gave a full update on the COVIDITY program and the goal of starting a Phase 1 clinical trial, to determine the safety and immune responses to the vaccine, as soon...